Israeli startup Raziel Therapeutics has developed an injectable molecule that apparently melts away fat cells. The new synthetic small molecule was discovered by Professor Shmuel Ben-Sasson of Hebrew University almost by accident. Raziel is conducting phase 2a clinical testing on 32 US patients.
I reported previously on the Artificial Intelligence (AI) platform of Israel’s MedyMatch for diagnosing head trauma and strokes from CT-scans. MedyMatch is now partnering with GE Healthcare to integrate its products with the US giant’s imaging solutions.
Israeli biotech Butterfly Medical has received the CE Mark for its novel medical device for non-surgical treatment of Benign Prostate Hyperplasia (BPH) or enlarged prostate that affects 105 million men globally. The device is inserted in a 10-minute procedure under local anesthetic.
Scientists at Israel’s Weizmann Institute have discovered that people with Autism react differently to certain odors produced by the human body. Experiments using sweat collected from people taking skydiving classes and from those undertaking normal exercise had remarkably different results.
I reported previously on the annual fund-raising “Hole in One” golf tournament of Israeli cancer charity Ezer Mizion. For the first time, a team of cancer patients also competed. The team not only won one of the top awards, but the patients benefited from a wonderful day out.
Eli Beer, founder and President of United Hatzalah was flying El Al from New York to Israel when he rushed to save the life of a passenger who was having a hypoglycemia attack. Using a borrowed glucometer, honey and jam he stabilized the patient so the flight could continue to Tel Aviv.
The security camera at a wedding venue captured the dramatic events after the band’s drummer began choking food that he’d swallowed. Luckily, one of the guests was United Hatzalah EMT Mordechai Mammon who used the Heimlich maneuver to save the drummer’s life.
Scientists at Israel’s Technion Institute and Tel Aviv University have reconnected severed spinal cords of rats. Previously paralyzed rodents were implanted with cells induced into a neural phenotype, and regained motor control. It could lead to major advances in treating spinal cord injury.
I reported previously on Israel’s Medial EarlySign and its blood test for early detection of colon cancer. Now Medial has developed an algorithm with a 64% success rate for identifying which of 645,000 prediabetics were at risk of becoming diabetics within 12 months.
Israeli biotech Pluristem has opened clinical centers in Israel and extended the trial of its stem cell treatment for insufficient hematopoietic recovery following hematopoietic cell transplantation (HCT). HCT is performed when bone marrow fails for reasons including cancer treatment.